Bernstein Liebhard LLP Launches Uloric Lawsuit Investigation, After FDA Concludes Febuxostat Increases Risk for Heart-Related Death and Death from All Causes Compared to Alternative Gout Medication

[In The News]

NEW YORK, March 7, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, is investigating potential legal claims on behalf of patients who died or were hospitalized for heart attacks, strokes, blood clots, and...

View the full article